Ionizable Lipid Compositions for Safe Intracellular RNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The effective targeted delivery of biologically active substances such as small molecule drugs, proteins, and nucleic acids to cells is hindered by their instability and low cell permeability, with existing lipid-containing nanoparticle compositions lacking in safety, efficacy, and specificity.
Innovation Solution
Development of novel compounds and compositions, including cationic and/or ionizable lipids, phospholipids, and PEG lipids, formulated into lipid nanoparticle compositions to enhance delivery of therapeutic and/or prophylactic agents to mammalian cells or organs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nucleic acids are delivered directly to cells, then therapeutic effect can be achieved, but cell permeability is too low and instability is high
Solution Approach 1:
The patent uses lipid nanoparticles as intermediary carriers to deliver nucleic acids to cells. The lipid nanoparticle composition includes ionizable lipids, phospholipids, and other components that form a protective carrier system, enabling the nucleic acid to be transported through biological barriers without direct contact, thus solving both the stability and cell permeability problems
2Stability of the object's composition
If cationic lipids are used in nanoparticle compositions, then cell permeability improves, but safety and specificity are reduced
Solution Approach 1:
The patent employs ionizable lipids that change their charge state based on pH environment. At acidic pH (endosomal/lysosomal compartments), the lipids become cationic to facilitate membrane disruption and escape, while at physiological pH (blood circulation), they remain neutral to reduce toxicity and improve safety. This dynamic parameter change resolves the contradiction between cell permeability and safety
Solution Approach 2:
The lipid nanoparticle composition is designed with different lipid components having specific functions: ionizable lipids for endosomal escape, PEGylated lipids for steric stabilization and reduced opsonization, and cholesterol for membrane fluidity modulation. Each component contributes locally to specific properties, enabling the overall system to achieve both high cell permeability and improved safety profile
3Ease of operation
If existing lipid nanoparticle compositions are used, then some delivery capability is achieved, but efficacy and specificity are insufficient
Solution Approach 1:
The patent develops a composite lipid nanoparticle formulation containing multiple carefully selected components: ionizable lipids (e.g., SM-102, ALC-0315), phospholipids (e.g., DSPC), PEGylated lipids (e.g., DMG-PEG2000), and cholesterol. This composite material approach combines the advantages of each component to achieve synergistic effects, significantly improving delivery efficacy, cellular uptake, and target specificity compared to simple lipid mixtures
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel compositions improve the safety, efficacy, and specificity of intracellular delivery of therapeutic agents, addressing the challenges of instability and low cell permeability.
Implementation Method 1
Lipid-containing nanoparticle compositions, liposomes, and lipoplexes have proven effective as transport vehicles into cells and/or intracellular compartments for biologically active substances
Implementation Method 2
Lipid-containing nanoparticle compositions, liposomes, and lipoplexes have proven effective as transport vehicles into cells and/or intracellular compartments
Implementation Method 3
Cationic and/or ionizable lipids include, for example, amine-containing lipids that can be readily protonated
Data Source
AI summary
The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.